Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
The Globe and Mail
21h
NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates
Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury (SCI) is approaching completion NVG-300 preclinical test-of-concept studies ...
18h
on MSN
Scientists discover 'entirely unanticipated' role of protein netrin1 in spinal cord development
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have uncovered an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tapped for health secretary
Charged over Capitol riot
18 states sue SEC, Gensler
NYC reviving congestion fee
IN gender-affirming care ban
To run Interior Department
New Jersey forest fire arrest
Alleged ISIS support charge
Leonid meteor shower
CDC: OD deaths down
OH trans bathroom bill
Ben & Jerry's sues Unilever
Bohannan requests recount
Vonn ending her retirement
FBI offering up to $25K
Named grand marshal
Tropical Storm Sara forms
Bed rails recalled
To close hundreds of stores
E. coli cases climb to 104
EU fines Meta
Weekly jobless claims fall
Judge blocks name change
Seeks pause in docs appeal
Military suicides increased
DOJ report on Fulton jail
Israeli airstrikes hit Syria
China hacked telecom firms
To replace Kotb on 'Today'
Faces up to $165M penalty
House GOP conference chair
Feedback